Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $806.9900 (1.63%) ($793.5000 - $806.9900) on Fri. Aug. 11, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.7% (three month average) | RSI | 83 | Latest Price | $806.9900(1.63%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 1% a day on average for past five trading days. | Weekly Trend | REGN advances 3.6% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) XLV(52%) IBB(51%) XLF(42%) DIA(41%) SPY(39%) | Factors Impacting REGN price | REGN will decline at least -0.85% in a week (0% probabilities). VXX(-40%) VIXM(-36%) USO(-6%) GLD(-6%) UUP(-4%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.85% (StdDev 1.7%) | Hourly BBV | 1.6 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $787.91(2.42%) | 10 Day Moving Average | $770.54(4.73%) | 20 Day Moving Average | $751.21(7.43%) | To recent high | 0% | To recent low | 16.6% | Market Cap | $85.564b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |